https://store-images.s-microsoft.com/image/apps.1957.7f7ed746-baae-4942-8263-4c6f6dbd1063.292f2a00-3992-4950-aa2e-84c5833e8dc7.f3e32dc6-7219-433a-863e-6f861eba18c0

AEYE Health Diagnostic Screening

by AEYE Health, Inc.

Screening diabetics for diabetic retinopathy with AI instead of referring to a specialist

AEYE Diagnostic Screening (AEYE-DS) allows primary care providers to screen their diabetic patients for diabetic retinopathy using AI technology instead of referring them to specialists. AEYE-DS is FDA-cleared based on a large scale clinical study. Screening patients requires a single image per eye, and produces a result instantly and with best-in-class accuracy (Sensitivity 93%; Specificity 91.4%).
AEYE Health provides the only practical AI-based diagnostic screening solution for diabetic retinopathy. The procedure is reimbursable by primary care providers using a dedicated CPT code 92229.
Diabetic retinopathy screenings are required once a year for patients with diabetes. Studies show that less than 50% of patients make their annual screening appointments, which translates into significant care gaps and poor patient outcomes.

At a glance

https://store-images.s-microsoft.com/image/apps.43724.7f7ed746-baae-4942-8263-4c6f6dbd1063.292f2a00-3992-4950-aa2e-84c5833e8dc7.675aa511-6233-4fcc-9099-7b0e62f8598c
/staticstorage/linux/20241118.4/assets/videoOverlay_7299e00c2e43a32cf9fa.png
https://store-images.s-microsoft.com/image/apps.28519.7f7ed746-baae-4942-8263-4c6f6dbd1063.292f2a00-3992-4950-aa2e-84c5833e8dc7.a32174af-5489-4b5e-9445-7070734458cb